Novo Nordisk CEO Lars Fruergaard Jorgensen discusses earnings as well as the competitive landscape in the pharmaceutical sector. He speaks with Bloomberg's Katie Greifeld and Alix Steel.

Former SEC Chair Gary Gensler Talks SpaceX & Mega IPO Risks
09:04

Jim Chanos Talks SpaceX IPO
13:48

US Energy Secretary Chris Wright Talks Oil Flows Through Strait of Hormuz
26:52